Comparative oncology revealed strong COL12A1 expression in ESCC, BC, and GC, moderate in CRC, and minimal in TC and HCC (Figure S3b), likely reflecting definite myCAFs abundance (Figure 4c). This evidence concerns the gene COL12A1 and colorectal carcinoma.